J B Chemicals & Pharmaceuticals Ratios

J B Chemicals & Pharmaceuticals Ltd Ratios

The J B Chemicals & Pharmaceuticals Ltd Ratios page provides a complete fundamental analysis of J B Chemicals & Pharmaceuticals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking J B Chemicals & Pharmaceuticals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

J B Chemicals & Pharmaceuticals Ltd (NSE: JBCHEPHARM, BSE: 506943) is currently trading at ₹2053.50, with a market capitalization of ₹329.61B. As a major player in the Health technology sector and Pharmaceuticals: major industry, J B Chemicals & Pharmaceuticals Ltd remains a key stock for fundamental analysis using J B Chemicals & Pharmaceuticals Ltd Ratios.

J B Chemicals & Pharmaceuticals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The J B Chemicals & Pharmaceuticals Ltd P/E ratio currently stands at 39.03, making it one of the most tracked metrics in J B Chemicals & Pharmaceuticals Ltd Ratios.

Historically, the J B Chemicals & Pharmaceuticals Ltd P/E ratio has shown strong fluctuations:

• 2024: 39.03
• 2023: 47.33
• 2022: 37.66
• 2021: 31.62
• 2020: 21.63

The decline in J B Chemicals & Pharmaceuticals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The J B Chemicals & Pharmaceuticals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.36.

Historical P/B trend:

• 2024: 7.36
• 2023: 8.76
• 2022: 6.15
• 2021: 5.71

J B Chemicals & Pharmaceuticals Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The J B Chemicals & Pharmaceuticals Ltd P/S ratio currently stands at 6.61, an important part of J B Chemicals & Pharmaceuticals Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 6.61
• 2023: 7.54
• 2022: 4.93
• 2021: 5.07

A stable or declining J B Chemicals & Pharmaceuticals Ltd P/S ratio indicates cautious market sentiment.

J B Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio (P/CF)

The J B Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 28.69.

Historical J B Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio:

• 2024: 28.69
• 2023: 34.40
• 2022: 25.91
• 2021: 72.26
• 2020: 31.26

The declining J B Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

J B Chemicals & Pharmaceuticals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The J B Chemicals & Pharmaceuticals Ltd EV currently stands at ₹253.18B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 253.18B
• 2023: 260.75B
• 2022: 157.35B
• 2021: 121.85B

J B Chemicals & Pharmaceuticals Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The J B Chemicals & Pharmaceuticals Ltd EV/EBITDA ratio is currently 24.89, a key metric in J B Chemicals & Pharmaceuticals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 24.89
• 2023: 29.19
• 2022: 22.51
• 2021: 22.86

Stable J B Chemicals & Pharmaceuticals Ltd EV/EBITDA indicates balanced valuation.

J B Chemicals & Pharmaceuticals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The J B Chemicals & Pharmaceuticals Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.01
• 2023: 0.13
• 2022: 0.23
• 2021: 0.03

J B Chemicals & Pharmaceuticals Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The J B Chemicals & Pharmaceuticals Ltd ROE currently stands at 20.75%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 20.75
• 2023: 20.46
• 2022: 17.77
• 2021: 19.55

J B Chemicals & Pharmaceuticals Ltd demonstrates strong profitability and efficient capital utilization.

J B Chemicals & Pharmaceuticals Ltd Ratios Analysis Summary

The J B Chemicals & Pharmaceuticals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether J B Chemicals & Pharmaceuticals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking J B Chemicals & Pharmaceuticals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.